Claude Scheidegger

423 total citations
13 papers, 192 citations indexed

About

Claude Scheidegger is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Claude Scheidegger has authored 13 papers receiving a total of 192 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 5 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in Claude Scheidegger's work include Hepatitis C virus research (5 papers), Bacterial Identification and Susceptibility Testing (2 papers) and HIV, Drug Use, Sexual Risk (2 papers). Claude Scheidegger is often cited by papers focused on Hepatitis C virus research (5 papers), Bacterial Identification and Susceptibility Testing (2 papers) and HIV, Drug Use, Sexual Risk (2 papers). Claude Scheidegger collaborates with scholars based in Switzerland, United States and Austria. Claude Scheidegger's co-authors include W. Zimmerli, Werner Zimmerli, Christian Meier, Christine Huber, Leticia Grize, Marius Kraenzlin, Peter Späth, R. Scherz, Andreas Schaffner and Philip Bruggmann and has published in prestigious journals such as Clinical Infectious Diseases, AIDS and Journal of Infection.

In The Last Decade

Claude Scheidegger

13 papers receiving 182 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claude Scheidegger Switzerland 7 87 47 39 31 27 13 192
Federica Sozio Italy 10 158 1.8× 93 2.0× 34 0.9× 38 1.2× 17 0.6× 27 309
P.P. Koopmans Netherlands 8 37 0.4× 44 0.9× 29 0.7× 21 0.7× 8 0.3× 15 173
Viviane Câmara Maniero Brazil 7 121 1.4× 88 1.9× 85 2.2× 59 1.9× 8 0.3× 12 320
Dilek Yılmaz Çiftdoğan Türkiye 10 129 1.5× 66 1.4× 27 0.7× 44 1.4× 12 0.4× 52 273
Anela Kellogg United States 8 93 1.1× 116 2.5× 28 0.7× 27 0.9× 22 0.8× 8 264
Raúl Bustos Chile 10 76 0.9× 45 1.0× 34 0.9× 89 2.9× 5 0.2× 48 309
Adolfo Martínez Spain 8 86 1.0× 46 1.0× 47 1.2× 55 1.8× 41 1.5× 23 276
Philip N. Okafor United States 11 157 1.8× 94 2.0× 38 1.0× 81 2.6× 11 0.4× 32 299
P. H. J. Frissen Netherlands 13 141 1.6× 302 6.4× 16 0.4× 27 0.9× 48 1.8× 27 534
Ishani Bora India 7 92 1.1× 142 3.0× 19 0.5× 19 0.6× 40 1.5× 24 256

Countries citing papers authored by Claude Scheidegger

Since Specialization
Citations

This map shows the geographic impact of Claude Scheidegger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Scheidegger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Scheidegger more than expected).

Fields of papers citing papers by Claude Scheidegger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude Scheidegger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Scheidegger. The network helps show where Claude Scheidegger may publish in the future.

Co-authorship network of co-authors of Claude Scheidegger

This figure shows the co-authorship network connecting the top 25 collaborators of Claude Scheidegger. A scholar is included among the top collaborators of Claude Scheidegger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude Scheidegger. Claude Scheidegger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bregenzer, Andrea, Philip Bruggmann, Erika Castro, et al.. (2021). Hepatitis C virus elimination in Swiss opioid agonist therapy programmes – the SAMMSU cohort. Swiss Medical Weekly. 151(910). w20460–w20460. 10 indexed citations
2.
Bruggmann, Philip, Andreas Cerny, Olivia Keiser, et al.. (2021). Empfehlungen für die Nachsorge von Patientinnen/Patienten mit ausgeheilter Hepatitis C. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. 1 indexed citations
3.
Bihl, Florian, Philip Bruggmann, Jean‐François Dufour, et al.. (2021). HCV disease burden and population segments in Switzerland. Liver International. 42(2). 330–339. 9 indexed citations
4.
Scheidegger, Claude, et al.. (2020). Oral antibiotic therapy in people who inject drugs (PWID) with bacteraemia. Swiss Medical Weekly. 150(2324). w20259–w20259. 5 indexed citations
5.
Bruggmann, Philip, Andreas Cerny, Montserrat Fraga, et al.. (2018). Versorgungslücken schliessen beim Testen auf virale Hepatitis. Schweizerische Ärztezeitung. 2 indexed citations
6.
Vernazza, Pietro, Sarah Tschudin‐Sutter, Andreas Kronenberg, et al.. (2018). Entwicklung infektiologischer Guidelines – ein kontinuierlicher Prozess. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. 1 indexed citations
7.
Huber, Christine, et al.. (2016). Bone mineral density and its determinants in men with opioid dependence. Journal of Bone and Mineral Metabolism. 35(1). 99–107. 38 indexed citations
8.
Trellu, Laurence Toutous, Peter Itin, Hansjakob Furrer, et al.. (2014). Gonorrhoe: neue Empfehlungen zu Diagnostik und Behandlung. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. 14(20). 1 indexed citations
9.
Mertz, Dominik, Reno Frei, Claude Scheidegger, et al.. (2010). Eradication of an epidemic methicillin-resistant Staphylococcus aureus (MRSA) from a geriatric university hospital: evidence from a 10-year follow-up. European Journal of Clinical Microbiology & Infectious Diseases. 29(8). 987–993. 6 indexed citations
10.
Scheidegger, Claude, et al.. (1997). Routinemäßige bakteriologische Kontrolluntersuchungen bei Intensivpatienten: Pro und Kontra. AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 32(2). 115–119. 2 indexed citations
11.
Scheidegger, Claude & Werner Zimmerli. (1996). Incidence and spectrum of severe medical complications among hospitalized HIV-seronegative and HIV-seropositive narcotic drug users. AIDS. 10(12). 1407–1414. 26 indexed citations
12.
Zimmerli, W., Andreas Schaffner, Claude Scheidegger, R. Scherz, & Peter Späth. (1991). Humoral immune response to pneumococcal antigen 23-F in an asplenic patient with recurrent fulminant pneumococcaemia. Journal of Infection. 22(1). 59–69. 17 indexed citations
13.
Scheidegger, Claude & W. Zimmerli. (1989). Infectious Complications in Drug Addicts: Seven-Year Review of 269 Hospitalized Narcotics Abusers in Switzerland. Clinical Infectious Diseases. 11(3). 486–493. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Federica Sozio Breakdown of academic impact, for papers by P.P. Koopmans Breakdown of academic impact, for papers by Viviane Câmara Maniero Breakdown of academic impact, for papers by Dilek Yılmaz Çiftdoğan Breakdown of academic impact, for papers by Anela Kellogg Breakdown of academic impact, for papers by Raúl Bustos Breakdown of academic impact, for papers by Adolfo Martínez Breakdown of academic impact, for papers by Philip N. Okafor Breakdown of academic impact, for papers by P. H. J. Frissen Breakdown of academic impact, for papers by Ishani Bora
Rankless by CCL
2026